Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16943400 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer
Condition: Non Muscle Invasive Bladder Cancer
Intervention: Drug: Celecoxib
2 Completed Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Drug: celecoxib;   Other: placebo

Indicates status has not been verified in more than two years